Stay updated on Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the error page. The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T21:47:17.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-06T21:51:29.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Access to the study record now results in a 403 Forbidden error page, replacing the expected content with an access-denied message.
    Difference
    19%
    Check dated 2026-09-22T23:23:45.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The Publications section now includes a new 2026 JAMA Oncology publication citation related to KEYNOTE-826, and the revision tag indicates version 3.7.0 (replacing the prior 3.6.6).
    Difference
    0.0%
    Check dated 2026-09-15T22:28:24.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.6.6 was added, and Plain Language Summary as well as Revision: v3.6.5 were removed from the page. This reflects an update to the page's revision history and the removal of a lay-friendly overview from the study record.
    Difference
    0.0%
    Check dated 2026-09-01T20:00:44.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    - The page now shows an explicit NIH grant/contract entry (2018) under Other Study ID Numbers, signaling a funding source for the trial.
    Difference
    0.0%
    Check dated 2026-08-25T19:21:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo vs Placebo in Cervical Cancer Clinical Trial page.